Human NK cells and cancer.

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Natural Killer (NK) cells were discovered ~50 years ago, initially recognized for their cytotoxic activity.
• Early research aimed to utilize NK cells as a universal anti-tumor immune tool, but their complexity became apparent.
• Despite progress, fully controlling NK cell function for immunotherapy remains challenging.

Purpose of the Study:

• To explore the intricate mechanisms governing NK cell function and heterogeneity.
• To understand how NK cells adapt their potential in response to environmental cues.
• To pave the way for advanced, personalized NK cell-based cancer therapies.

Main Methods:

• Analysis of epigenetic calibration of NK cell functional potential.
• Investigation of NK cell interactions with other immune cells (e.g., myeloid-derived suppressor cells, dendritic cells).
• Examination of NK cell receptor engagement (immune checkpoints, cytokines, ligands, ADCC).

Main Results:

• NK cells exhibit epigenetic plasticity, generating diverse subpopulations like memory-like, tissue-resident, and varied differentiation/functional states.
• NK cell activity is modulated by complex signaling networks, including cellular interactions and receptor engagement.
• The concept of generalized NK cell exploitation is evolving towards sophisticated therapeutic strategies.

Conclusions:

• NK cell function is highly adaptable and context-dependent, challenging simplistic therapeutic approaches.
• Personalized and combination immunotherapies, potentially involving genetically modified NK cells, are emerging.
• Future strategies will focus on strengthening and redirecting NK cell effector functions against cancer.